Safety and Tolerability of a Modified Vaccinia Ankara (MVA)-Based Vaccine Modified to Express Brachyury and T-cell Costimulatory Molecules (MVA-Brachyury-TRICOM)
Clinical trial NCT02179515 · COMPLETED
Trial details
- NCT number
- NCT02179515
- Sponsor
- National Cancer Institute (NCI)
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2014-06-28
- Primary completion
- 2017-04-06
- Enrollment
- 38
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.